Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ORIC | Oric Pharmaceuticals, Inc. | Director | $264K | +$263K | +23041% | Jun 20, 2025 |
RYZB | RayzeBio, Inc. | Director | Feb 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|